{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T23:25:16Z","timestamp":1791761116389,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11916-021-00936-5","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T13:02:43Z","timestamp":1616504563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Carnitine Responsive Migraine Headache Syndrome: Case Report and Review of the Literature"],"prefix":"10.1007","volume":"25","author":[{"suffix":"IV","given":"Larry","family":"Charleston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suad","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"issue":"1","key":"936_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yexmp.2006.09.008","volume":"83","author":"SR Pieczenik","year":"2007","unstructured":"Pieczenik SR, Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol. 2007;83(1):84\u201392. https:\/\/doi.org\/10.1016\/j.yexmp.2006.09.008.","journal-title":"Exp Mol Pathol"},{"issue":"4","key":"936_CR2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1042\/bj1361083","volume":"136","author":"RA Cox","year":"1973","unstructured":"Cox RA, Hoppel CL. Biosynthesis of carnitine and 4-N-trimethylaminobutyrate from 6-N-trimethyl-lysine. Biochem J. 1973;136(4):1083\u201390. https:\/\/doi.org\/10.1042\/bj1361083.","journal-title":"Biochem J"},{"issue":"3","key":"936_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ymgme.2015.09.004","volume":"116","author":"AW El-Hattab","year":"2015","unstructured":"El-Hattab AW, Scaglia F. Disorders of carnitine biosynthesis and transport. Mol Genet Metab. 2015;116(3):107\u201312. https:\/\/doi.org\/10.1016\/j.ymgme.2015.09.004.","journal-title":"Mol Genet Metab"},{"issue":"7","key":"936_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0968-0004(03)00137-3","volume":"28","author":"RR Ramsay","year":"2003","unstructured":"Ramsay RR, Naismith JH. A snapshot of carnitine acetyltransferase. Trends Biochem Sci. 2003;28(7):343\u20136. https:\/\/doi.org\/10.1016\/S0968-0004(03)00137-3.","journal-title":"Trends Biochem Sci"},{"issue":"4 Suppl 4","key":"936_CR5","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/s0272-6386(03)00112-4","volume":"41","author":"C Hoppel","year":"2003","unstructured":"Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis. 2003;41(4 Suppl 4):S4\u201312. https:\/\/doi.org\/10.1016\/s0272-6386(03)00112-4.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"936_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ajmg.c.30087","volume":"142C","author":"N Longo","year":"2006","unstructured":"Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C: Semin Med Genet. 2006;142C(2):77\u201385. https:\/\/doi.org\/10.1002\/ajmg.c.30087.","journal-title":"Am J Med Genet C: Semin Med Genet"},{"issue":"10","key":"936_CR7","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","volume":"1863","author":"N Longo","year":"2016","unstructured":"Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta. 2016;1863(10):2422\u201335. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.01.023An update on carnitine transport and fatty acid oxidation.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"936_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ymgme.2009.12.015","volume":"100","author":"NC Lee","year":"2010","unstructured":"Lee NC, Tang NL, Chien YH, Chen CA, Lin SJ, Chiu PC, et al. Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. Mol Genet Metab. 2010 May;100(1):46\u201350. https:\/\/doi.org\/10.1016\/j.ymgme.2009.12.015.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"936_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/GIM.0b013e3181c5e6f7","volume":"12","author":"AW El-Hattab","year":"2010","unstructured":"El-Hattab AW, Li FY, Shen J, Powell BR, Bawle EV, Adams DJ, et al. Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. Genet Med. 2010;12(1):19\u201324. https:\/\/doi.org\/10.1097\/GIM.0b013e3181c5e6f7.","journal-title":"Genet Med"},{"issue":"4","key":"936_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ymgme.2006.10.003","volume":"90","author":"LA Schimmenti","year":"2007","unstructured":"Schimmenti LA, Crombez EA, Schwahn BC, Heese BA, Wood TC, Schroer RJ, et al. Expanded newborn screening identifies maternal primary carnitine deficiency. Mol Genet Metab. 2007;90(4):441\u20135. https:\/\/doi.org\/10.1016\/j.ymgme.2006.10.003.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"936_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10545-006-0376-y","volume":"29","author":"S Vijay","year":"2006","unstructured":"Vijay S, Patterson A, Olpin S, Henderson MJ, Clark S, Day C, et al. Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants. J Inherit Metab Dis. 2006;29(5):627\u201330. https:\/\/doi.org\/10.1007\/s10545-006-0376-y.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"936_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-0404.1995.tb01697.x","volume":"92","author":"CC Hsu","year":"1995","unstructured":"Hsu CC, Chuang YH, Tsai JL, et al. CPEO and carnitine deficiency overlapping in MELAS syndrome. Acta Neurol Scand. 1995;92(3):252\u20135. https:\/\/doi.org\/10.1111\/j.1600-0404.1995.tb01697.x.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"936_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1046\/j.1526-4610.2003.03095.x","volume":"43","author":"MA Kabbouche","year":"2003","unstructured":"Kabbouche MA, Powers SW, Vockell AL, et al. Carnitine palmityltransferase II (CPT2) deficiency and migraine headache: two case reports. Headache. 2003;43(5):490\u20135. https:\/\/doi.org\/10.1046\/j.1526-4610.2003.03095.x.","journal-title":"Headache"},{"key":"936_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.biopha.2018.03.059","volume":"102","author":"E Nattagh-Eshtivani","year":"2018","unstructured":"Nattagh-Eshtivani E, Sani MA, Dahri M, Ghalichi F, Ghavami A, Arjang P, et al. The role of nutrients in the pathogenesis and treatment of migraine headaches: review. Biomed Pharmacother. 2018;102:317\u201325. https:\/\/doi.org\/10.1016\/j.biopha.2018.03.059Role of nutrients in migraine pathophysiology and treatment.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"936_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.brainres.2005.11.052","volume":"1070","author":"Y Kira","year":"2006","unstructured":"Kira Y, Nishikawa M, Ochi A, et al. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis. Brain Res. 2006;1070(1):206\u201314. https:\/\/doi.org\/10.1016\/j.brainres.2005.11.052.","journal-title":"Brain Res"},{"issue":"Suppl 1","key":"936_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2165\/00023210-200721001-00004","volume":"21","author":"M Youle","year":"2007","unstructured":"Youle M. Acetyl-L-carnitine in HIV-associated antiretroviral toxic neuropathy. CNS Drugs. 2007;21(Suppl 1):25\u201330; discussion 45-6. https:\/\/doi.org\/10.2165\/00023210-200721001-00004.","journal-title":"CNS Drugs"},{"key":"936_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1468-1293.2007.00467.x","volume":"8","author":"M Youle","year":"2007","unstructured":"Youle M, Osio M, ALCAR Study Group. A double- blind, parallel-group, placebo-controlled, multicentre study of acetyl l-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection. HIV Med. 2007;8:241\u201350.","journal-title":"HIV Med"},{"key":"936_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/ajmg.a.32268","volume":"146A","author":"MG Torrioli","year":"2008","unstructured":"Torrioli MG, Vernacotola S, Peruzzi L, et al. A double- blind, parallel, multicenter comparison of l-acetylcarni- tine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys. Am J Med Genet A. 2008;146A:803\u201312.","journal-title":"Am J Med Genet A"},{"key":"936_CR19","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1200\/JCO.2012.44.8738","volume":"31","author":"DL Hershman","year":"2013","unstructured":"Hershman DL, Unger JM, Crew KD, et al. Randomized double-blind placebo-controlled trial of acetyl-l-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol. 2013;31:2627\u201333.","journal-title":"J Clin Oncol"},{"issue":"1-3","key":"936_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12011-012-9487-5","volume":"150","author":"A Tarighat Esfanjani","year":"2012","unstructured":"Tarighat Esfanjani A, Mahdavi R, Ebrahimi Mameghani M, et al. The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis. Biol Trace Elem Res. 2012;150(1-3):42\u20138. https:\/\/doi.org\/10.1007\/s12011-012-9487-5.","journal-title":"Biol Trace Elem Res"},{"issue":"11","key":"936_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1177\/0333102414566817","volume":"35","author":"K Hagen","year":"2015","unstructured":"Hagen K, Brenner E, Linde M, et al. Acetyl-l-carnitine versus placebo for migraine prophylaxis: a randomized, triple-blind, crossover study. Cephalalgia. 2015;35(11):987\u201395. https:\/\/doi.org\/10.1177\/0333102414566817Recent randomized triple blinded crossover placebo control trial of Acetyl-L-carnitive in migraine prevention.","journal-title":"Cephalalgia"},{"issue":"6","key":"936_CR22","first-page":"1065","volume":"72","author":"RA Bonakdar","year":"2005","unstructured":"Bonakdar RA, Guarneri E. Coenzyme Q10. Am Fam Physician. 2005;72(6):1065\u201370.","journal-title":"Am Fam Physician"},{"issue":"5","key":"936_CR23","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1177\/0333102418821661","volume":"39","author":"P Hajihashemi","year":"2019","unstructured":"Hajihashemi P, Askari G, Khorvash F, et al. The effects of concurrent Coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial. Cephalalgia. 2019;39(5):648\u201354. https:\/\/doi.org\/10.1177\/0333102418821661Recent randomized double blinded placebo control trial of L-carnitive in migraine prevention.","journal-title":"Cephalalgia"},{"issue":"2","key":"936_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1468-2982.2002.00335.x","volume":"22","author":"TD Rozen","year":"2002","unstructured":"Rozen TD, Oshinsky ML, Gebeline CA, et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia. 2002;22(2):137\u201341. https:\/\/doi.org\/10.1046\/j.1468-2982.2002.00335.x.","journal-title":"Cephalalgia"},{"issue":"4","key":"936_CR25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s0361-9230(01)00440-3","volume":"54","author":"R Lodi","year":"2001","unstructured":"Lodi R, Iotti S, Cortelli P, et al. Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache. Brain Res Bull. 2001;54(4):437\u201341. https:\/\/doi.org\/10.1016\/s0361-9230(01)00440-3.","journal-title":"Brain Res Bull"},{"issue":"5","key":"936_CR26","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1046\/j.1471-4159.2001.00621.x","volume":"79","author":"Y Kido","year":"2001","unstructured":"Kido Y, Tamai I, Ohnari A, et al. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J Neurochem. 2001;79(5):959\u201369. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00621.x.","journal-title":"J Neurochem"},{"issue":"Suppl 1","key":"936_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2165\/00023210-200721001-00005","volume":"21","author":"S Chiechio","year":"2007","unstructured":"Chiechio S, Copani A, Gereau RW, et al. Acetyl-L-carnitine in neuropathic pain: experimental data. CNS Drugs. 2007;21(Suppl 1):31\u20138; discussion 45-6. https:\/\/doi.org\/10.2165\/00023210-200721001-00005.","journal-title":"CNS Drugs"},{"issue":"14","key":"936_CR28","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.addr.2009.04.024","volume":"61","author":"VA Zammit","year":"2009","unstructured":"Zammit VA, Ramsay RR, Bonomini M, et al. Carnitine, mitochondrial function and therapy. Adv Drug Deliv Rev. 2009;61(14):1353\u201362. https:\/\/doi.org\/10.1016\/j.addr.2009.04.024.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"936_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10194-008-0006-1","volume":"9","author":"A Panconesi","year":"2008","unstructured":"Panconesi A. Alcohol and migraine: trigger factor, consumption, mechanisms, A review. J Headache Pain. 2008;9(1):19\u201327. https:\/\/doi.org\/10.1007\/s10194-008-0006-1.","journal-title":"J Headache Pain"},{"issue":"5","key":"936_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1530-0277.1988.tb00259.x","volume":"12","author":"S Adamo","year":"1988","unstructured":"Adamo S, Siliprandi N, Dl Lisa F, et al. Effect of L-carnitine on ethanol and acetate plasma levels after oral administration of ethanol in humans. Alcohol Clin Exp Res. 1988;12(5):653\u20134. https:\/\/doi.org\/10.1111\/j.1530-0277.1988.tb00259.x.","journal-title":"Alcohol Clin Exp Res"},{"issue":"Suppl 2","key":"936_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1526-4610.2012.02233.x","volume":"52","author":"HG Markley","year":"2012","unstructured":"Markley HG. CoEnzyme Q10 and riboflavin: the mitochondrial connection. Headache. 2012;52(Suppl 2):81\u20137. https:\/\/doi.org\/10.1111\/j.1526-4610.2012.02233.x.","journal-title":"Headache"},{"issue":"3","key":"936_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.spen.2013.09.002","volume":"20","author":"WR Yorns Jr","year":"2013","unstructured":"Yorns WR Jr, Hardison HH. Mitochondrial dysfunction in migraine. Semin Pediatr Neurol. 2013;20(3):188\u201393. https:\/\/doi.org\/10.1016\/j.spen.2013.09.002.","journal-title":"Semin Pediatr Neurol"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-021-00936-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-021-00936-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-021-00936-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T09:17:18Z","timestamp":1616836638000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-021-00936-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["936"],"URL":"https:\/\/doi.org\/10.1007\/s11916-021-00936-5","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"19 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Charleston has served as consultant and advisory board member or has received honoraria from AbbVie, Alder, and Biohaven. <i>He has performed\u00a0<\/i><i>medical legal consultation for the Vaccine Injury Compensation Program<\/i>. He is on the advisory board of BrainWeekend and Ctrl M Health. He is an\u00a0Associate Editor of Headache: The Journal of Head and Face Pain.Dr. Khalil has received research support from Eli Lilly with no conflict of interest with this manuscript.Dr. Young reports grants and personal fees from Allergan, grants and personal fees from Amgen, personal fees from Avanir, grants and personal fees from Alder (now Lundbeck), personal fees from Cipla, grants and personal fees from Eli Lilly, personal fees from Supernus, grants from Autonomic Technologies, grants from Colucid, grants from Cumberland, grants from Dr. Reddy Laboratories, grants from Novartis, grants and personal fees from PCORI, grants from Scion, grants and personal fees from Teva, grants from Zosano, personal fees from Promius, personal fees from Biohaven, personal fees from Theranica, and grants from Satsuma, outside the submitted work; he is an Advising Physician and Chairman of the Board for the Coalition for Headache and Migraine Patients (CHAMP), President for Miles for Migraine, and Co-Medical Director of Ctrl M Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"26"}}